MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- DR. REDDYS LAB
DR. REDDYS LAB Share Price (REDY)
Here is the latest stock price and chart of Dr. Reddys. For more details, see the Dr. Reddys company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
EXPLORE: Here's How You Can Get 1 YEAR of Our Proven Smallcap Service for FREE...
| Live BSE Quotes | Aug 14, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)4,520.55 | Open (Rs) 4,511.00 | High (Rs) 4,584.40 | Low (Rs) 4,470.00 |
| % Change0.36 | Volume 34,647 | Value (Rs) 156,999,598 | 52-Week H/L 4,754.30 / 2,466.00 |
| Live NSE Quotes | Aug 14, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)4,519.40 | Open (Rs) 4,526.15 | High (Rs) 4,586.00 | Low (Rs) 4,470.00 |
| % Change0.38 | Volume 1,150,830 | Value (Rs) 5,219,854,355 | 52-Week H/L 4,758.60 / 2,465.00 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day 0.36% | 1 Month 13.48% | 3 Months 21.12% | 1 Year 80.02% | 5 Years (CAGR)* 1.20% | 10 Years (CAGR)* 12.80% |
* Compound Annual Growth Rate
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 114.45 | P/E Ratio (x) 39.50 | Market Cap (Rs m) 749,100.34 | P/BV (x) 5.34 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
DR. REDDYS LAB Share Price Today:
DR. REDDYS LAB last traded price was up 0.4% to Rs 4,520.6 on the BSE. On the NSE, DR. REDDYS LAB last traded price was up 0.4% to Rs 4,519.4. The total volume of shares traded was 1.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.8%. And the benchmark S&P BSE SENSEX was at 37,877.3 (down 1.1%).
Over the last 30 days, the DR. REDDYS LAB share price is up 13.5%. And over the last one year, DR. REDDYS LAB share price is up 80.0%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
Today's Market
Sensex Crashes 433 Points; Banking and Auto Stocks Bleed(Closing)
Indian share markets ended on a negative note today amid a huge selloff in auto and banking stocks.
Related Views On News
DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)
Feb 4, 2019 | Updated on Feb 4, 2019For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.
More Views on NewsMost Popular
Large Opportunities Are Coming Our Way
Aug 5, 2020Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.
Is It Time to Book Profits in Gold and Silver? (Fast Profits Daily)
Aug 10, 2020Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?
Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks (Profit Hunter)
Aug 6, 2020Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.
3 Stocks to Ride the Big Rebound in Smallcaps (Profit Hunter)
Aug 11, 2020The rebound ratio suggests that smallcaps are set for big gains but this time it will be limited to a few stocks. Make sure you choose wisely.
Governance: for the country and your portfolio. (The Honest Truth)
Aug 14, 2020Ajit Dayal on the need of socially responsible governance.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2020
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK DR. REDDYS LAB
- Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON DR. REDDYS LAB
DR. REDDYS LAB - MYLAN COMPARISON
COMPARE DR. REDDYS LAB WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.